Therapeutic Potential of Bioactive Components from Scutellaria baicalensis Georgi in Inflammatory Bowel Disease and Colorectal Cancer: A Review

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Anti‐ulcerative effects of wogonin on ulcerative colitis induced by dextran sulfate sodium via Nrf2/ TLR4 / NF‐κB signaling pathway in BALB /c mice

(2022) Yadong Zhou et al.   ENVIRONMENTAL TOXICOLOGY

Transport and Interactions of Co-incubated Bi-functional Flavonoids through Inhibiting the Function of P-Glycoprotein (P-gp) Using KB/Multidrug-Resistant (MDR) Cells and Rat Everted Gut Sacs

(2022) Yajing Fang et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Inflammatory bowel disease biomarkers

(2022) Dandan Liu et al.   MEDICINAL RESEARCH REVIEWS

Prediction of Cancer Incidence and Mortality in Korea, 2022

(2022) Kyu-Won Jung et al.   Cancer Research and Treatment

Antiviral activity and underlying mechanisms of Baicalin against avian infectious bronchitis virus in vitro

(2022) Haipeng Feng et al.   AVIAN PATHOLOGY

NF-κB: blending metabolism, immunity, and inflammation

(2022) Daria Capece et al.   TRENDS IN IMMUNOLOGY

Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review

(2022) Risha Ganguly et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease

(2022) Brunette Katsandegwaza et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

BCL-2 protein family: attractive targets for cancer therapy

(2022) Deeksha Kaloni et al.   APOPTOSIS

Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review

(2022) Jung Yoon Jang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial

(2022) Qiaoling Wang et al.   PLoS One

Baicalin-Induced Autophagy Preserved LPS-Stimulated Intestinal Cells from Inflammation and Alterations of Paracellular Permeability

(2021) Valentina Rizzo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease

(2021) Lauren O'Connell et al.   Frontiers in Pediatrics

Necroptosis, pyroptosis and apoptosis: an intricate game of cell death

(2021) Damien Bertheloot et al.   Cellular & Molecular Immunology

Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer

(2021) Kristiina Rajamäki et al.   GASTROENTEROLOGY

Effects of Qing Chang Suppository Powder and its Ingredients on IL-17 Signal Pathway in HT-29 Cells and DSS-induced Mice

(2021) Gui Zhou et al.   PHYTOMEDICINE

Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications

(2021) Xian Zhou et al.   BIOMEDICINE & PHARMACOTHERAPY

The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis

(2021) Babajide A Ojo et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines

(2021) Ross J Porter et al.   Journal of Crohns & Colitis

Wogonin Strengthens the Therapeutic Effects of Mesenchymal Stem Cells in DSS-Induced Colitis via Promoting IL-10 Production

(2021) Qiongli Wu et al.   Oxidative Medicine and Cellular Longevity

Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy

(2021) Li Xiang et al.   PHYTOMEDICINE

The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip

(2021) Shafaque Rahman et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles

(2021) Mohammad‐Javad Sanaei et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Therapeutic effect of baicalin on inflammatory bowel disease: A review

(2021) Xian Wang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Pteryxin attenuates LPS-induced inflammatory responses and inhibits NLRP3 inflammasome activation in RAW264.7 cells

(2021) Dong Zhen et al.   JOURNAL OF ETHNOPHARMACOLOGY

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

(2021) Marianna Lucafò et al.   Frontiers in Pharmacology

Treatment of Inflammatory Bowel Disease: A Comprehensive Review

(2021) Zhaobei Cai et al.   Frontiers in Medicine

Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes

(2020) E.W. Baxter et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway

(2020) Shaowei Huang et al.   PHYTOMEDICINE

Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14

(2020) Ya-jun Fu et al.   ACTA PHARMACOLOGICA SINICA

Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis

(2020) Lei Zhu et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Exosome‐mediated effects and applications in inflammatory bowel disease

(2020) Dickson K. W. Ocansey et al.   BIOLOGICAL REVIEWS

Baicalin alleviates TNBS‑induced colitis by inhibiting PI3K/AKT pathway activation

(2020) Lei Zhu et al.   Experimental and Therapeutic Medicine

Location-specific cell identity rather than exposure to GI microbiota defines many innate immune signalling cascades in the gut epithelium

(2020) Ozge Kayisoglu et al.   GUT

Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa

(2020) Laura Weber et al.   Biomolecules

Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis

(2020) Chang Liu et al.   MEDIATORS OF INFLAMMATION

The role of medicinal products in the treatment of inflammatory bowel diseases ( IBD ) through inhibition of TLR4 / NF‐kappaB pathway

(2020) Pegah Dejban et al.   PHYTOTHERAPY RESEARCH

The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review

(2020) Hengfeng Liao et al.   BIOMEDICINE & PHARMACOTHERAPY

Organoid-based models to study the role of host-microbiota interactions in IBD

(2020) Martina Poletti et al.   Journal of Crohns & Colitis

Development of a human primary gut-on-a-chip to model inflammatory processes

(2020) Claudia Beaurivage et al.   Scientific Reports

Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways

(2019) Haidy E. Michel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Risk of colorectal cancer in inflammatory bowel diseases

(2019) Muhammad Shahid Nadeem et al.   SEMINARS IN CANCER BIOLOGY

The Ussing chamber system for measuring intestinal permeability in health and disease

(2019) Amanda Thomson et al.   BMC GASTROENTEROLOGY

PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence

(2019) Arunaksharan Narayanankutty   CURRENT DRUG TARGETS

Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease

(2019) Soo-Young Na et al.   Gut and Liver

Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology

(2019) Tiantian Zhao et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Demonstrating suitability of the Caco‐2 cell model for BCS ‐based biowaiver according to the recent FDA and ICH harmonised guidelines

(2019) Tina Jarc et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis

(2019) Jian Shen et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke

(2019) Sung Hyuk Heo et al.   MEDICINE

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

(2019) Qingdong Guan   Journal of Immunology Research

The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat

(2019) Shuai Liang et al.   Frontiers in Pharmacology

Apoptosis: A Target for Anticancer Therapy

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Deglycosylation of wogonoside enhances its anticancer potential

(2018) Chong-Zhi Wang et al.   Journal of Cancer Research and Therapeutics

Selective Anti-tumor Activity of wogonin targeting the Warburg Effect through stablizing p53

(2018) Yikai Zhao et al.   PHARMACOLOGICAL RESEARCH

Genomic characterization of colitis-associated colorectal cancer

(2018) Hitoshi Kameyama et al.   World Journal of Surgical Oncology

Anti-Inflammatory Effect of Baicalein on Polyinosinic–Polycytidylic Acid-Induced RAW 264.7 Mouse Macrophages

(2018) Young-Jin Kim et al.   Viruses-Basel

Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence

(2018) Jie Dou et al.   Oncotarget

Colorectal Cancer in Inflammatory Bowel Disease

(2018) Peter Higgins et al.   Clinics in Colon and Rectal Surgery

Cytokine Tuning of Intestinal Epithelial Function

(2018) Caroline Andrews et al.   Frontiers in Immunology

Toll-like Receptors and Inflammatory Bowel Disease

(2018) Yue Lu et al.   Frontiers in Immunology

Baicalein Inhibits Proliferation Activity of Human Colorectal Cancer Cells HCT116 Through Downregulation of Ezrin

(2018) Zhi Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs

(2018) Yili Tao et al.   Scientific Reports

Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation

(2018) Maria del Carmen Ponce de León-Rodríguez et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers

(2018) Kiril Lanevskij et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation

(2018) Qian Feng et al.   Frontiers in Pharmacology

Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor

(2018) Wenkang Ma et al.   ANTI-CANCER DRUGS

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression

(2017) Cheng-Liang Zhang et al.   LIFE SCIENCES

Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture

(2017) Isabel Lozoya-Agullo et al.   MOLECULAR PHARMACEUTICS

Chemically induced mouse models of acute and chronic intestinal inflammation

(2017) Stefan Wirtz et al.   Nature Protocols

The anti-metastatic effect of baicalein on colorectal cancer

(2017) Yuxia Chai et al.   ONCOLOGY REPORTS

A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions

(2017) Gaelle Noel et al.   Scientific Reports

Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in mice

(2017) Xiaoping Luo et al.   Scientific Reports

Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype

(2016) Wei Zhu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

An in vitro study of mucoadhesion and biocompatibility of polymer coated liposomes on HT29-MTX mucus-producing cells

(2016) Małgorzata I. Adamczak et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes

(2016) Kengo Nozaki et al.   JOURNAL OF GASTROENTEROLOGY

Anticancer properties of baicalein: a review

(2016) Ying Gao et al.   MEDICINAL CHEMISTRY RESEARCH

Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics

(2016) Keumhan Noh et al.   MOLECULES

Modulation of the Nrf2 signalling pathway in Hct116 colon carcinoma cells by baicalein and its methylated derivative negletein

(2016) Susannah Havermann et al.   PHARMACEUTICAL BIOLOGY

Protective effect of baicalin against experimental colitis via suppression of oxidant stress and apoptosis

(2016) Li-sheng Wang et al.   Pharmacognosy Magazine

Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway

(2016) Yang Sun et al.   Oncotarget

Risk of infections associated with biological treatment in inflammatory bowel disease

(2016) Nynne Nyboe Andersen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation

(2015) Yang Sun et al.   BIOCHEMICAL PHARMACOLOGY

Mitochondrial apoptosis: killing cancer using the enemy within

(2015) J Lopez et al.   BRITISH JOURNAL OF CANCER

Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro

(2015) Wenping Wang et al.   INFLAMMATION RESEARCH

Optimization of Caco-2 and HT29 co-culturein vitrocell models for permeability studies

(2015) Fengguang Pan et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin

(2015) CHONG-ZHI WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MicroRNA-181b regulates endotoxin tolerance by targeting IL-6 in macrophage RAW264.7 cells

(2015) Wenjun Zhang et al.   Journal of Inflammation-London

Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway

(2015) XIAOJIANG RUI et al.   Oncology Letters

Baicalin attenuates TNBS-induced colitis in rats by modulating the Th17/Treg paradigm

(2014) Ying Zou et al.   ARCHIVES OF PHARMACAL RESEARCH

Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions

(2014) Erika B Rangel   Expert Opinion on Drug Metabolism & Toxicology

The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation

(2014) Li Cui et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma

(2014) Stefan Salcher et al.   Molecular Cancer

Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis

(2014) Eun Ran Kim   WORLD JOURNAL OF GASTROENTEROLOGY

NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis

(2014) J Yao et al.   Cell Death & Disease

Anti-inflammatory Activity of Baicalein in LPS-Stimulated RAW264.7 Macrophages via Estrogen Receptor and NF-κB-Dependent Pathways

(2013) Guan-Wei Fan et al.   INFLAMMATION

Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production

(2013) Zhilin Qi et al.   INFLAMMATION RESEARCH

Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice

(2013) DONG HWAN KIM et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Wogonoside displays anti-inflammatory effects through modulating inflammatory mediator expression using RAW264.7 cells

(2013) Yao-Zhi Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Pretreatment of baicalin and wogonoside with glycoside hydrolase: A promising approach to enhance anticancer potential

(2013) CHUNHAO YU et al.   ONCOLOGY REPORTS

Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells

(2013) Licheng He et al.   TOXICOLOGY

Reply

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

(2012) Marte Lie Høivik et al.   GUT

Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells

(2012) SO-JUNG KIM et al.   Molecular Medicine Reports

Baicalin Induces Apoptosis in SW620 Human Colorectal Carcinoma Cells in Vitro and Suppresses Tumor Growth in Vivo

(2012) Wen-Cheng Chen et al.   MOLECULES

Alleviation of Gut Inflammation by Cdx2/Pxr Pathway in a Mouse Model of Chemical Colitis

(2012) Wei Dou et al.   PLoS One

Review article: loss of response to anti-TNF treatments in Crohn’s disease

(2011) S. Ben-Horin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Impacts of recent cultivation on genetic diversity pattern of a medicinal plant, Scutellaria baicalensis (Lamiaceae)

(2010) Qing-Jun Yuan et al.   BMC GENETICS

Colorectal Cancer in Inflammatory Bowel Disease

(2010) Jonathan Potack et al.   Gut and Liver

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

(2010) Matthieu Allez et al.   Journal of Crohns & Colitis

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin

(2008) Min Li-Weber   CANCER TREATMENT REVIEWS

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY